The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 14, 2025
Filed:
Jun. 29, 2023
Applicant:
Foundation Medicine, Inc., Cambridge, MA (US);
Inventors:
Siraj Mahamed Ali, Cambridge, MA (US);
Matthew J. Hawryluk, Newton, MA (US);
Jie He, Newton, MA (US);
Doron Lipson, Chestnut Hill, MA (US);
Vincent A. Miller, West Orange, NJ (US);
Jeffrey S. Ross, Lebanon Springs, NY (US);
Philip James Stephens, Lexington, MA (US);
Assignee:
Foundation Medicine, Inc., Boston, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/517 (2005.12); A61K 31/19 (2005.12); A61K 31/404 (2005.12); A61K 31/435 (2005.12); A61K 31/4412 (2005.12); A61K 31/4439 (2005.12); A61K 31/47 (2005.12); A61K 31/496 (2005.12); A61K 31/498 (2005.12); A61K 31/5025 (2005.12); A61K 31/506 (2005.12); A61K 31/519 (2005.12); A61K 31/53 (2005.12); A61K 31/5383 (2005.12); A61K 31/553 (2005.12); A61K 45/06 (2005.12); C07K 14/705 (2005.12); C07K 14/71 (2005.12); C07K 16/40 (2005.12); C12N 9/12 (2005.12); C12N 15/113 (2009.12); C12Q 1/6883 (2017.12); C12Q 1/6886 (2017.12); G01N 33/573 (2005.12);
U.S. Cl.
CPC ...
A61K 31/5025 (2012.12); A61K 31/404 (2012.12); A61K 31/435 (2012.12); A61K 31/4412 (2012.12); A61K 31/4439 (2012.12); A61K 31/47 (2012.12); A61K 31/496 (2012.12); A61K 31/498 (2012.12); A61K 31/506 (2012.12); A61K 31/517 (2012.12); A61K 31/519 (2012.12); A61K 31/53 (2012.12); A61K 31/5383 (2012.12); A61K 31/553 (2012.12); A61K 45/06 (2012.12); C07K 14/705 (2012.12); C07K 14/71 (2012.12); C07K 16/40 (2012.12); C12N 9/12 (2012.12); C12N 15/1137 (2012.12); C12Q 1/6883 (2012.12); C12Q 1/6886 (2012.12); C12Y 207/10001 (2012.12); G01N 33/573 (2012.12); C07K 2319/00 (2012.12); C12N 2310/11 (2012.12); C12N 2310/12 (2012.12); C12N 2310/14 (2012.12); C12Q 2600/156 (2012.12); C12Q 2600/158 (2012.12); G01N 2333/912 (2012.12); G01N 2500/04 (2012.12);
Abstract
Methods and compositions for treating cholangiocarcinoma.